<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d323" origId="Isosorbide Mononitrate"><sentence id="DrugDDI.d323.s0" origId="s0" text="The vasodilating effects of isosorbide mononitrate may be additive with those of other vasodilators."><entity id="DrugDDI.d323.s0.e0" origId="s0.p1" charOffset="28-50" type="drug" text="isosorbide mononitrate"/><entity id="DrugDDI.d323.s0.e1" origId="s0.p5" charOffset="87-99" type="drug" text="vasodilators"/><pair id="DrugDDI.d323.s0.p0" e1="DrugDDI.d323.s0.e0" e2="DrugDDI.d323.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d323.s1" origId="s1" text="Alcohol, in particular, has been found to exhibit additive effects of this variety."><entity id="DrugDDI.d323.s1.e0" origId="s1.p6" charOffset="0-7" type="drug" text="Alcohol"/></sentence><sentence id="DrugDDI.d323.s2" origId="s2" text="Marked symptomatic orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used in combination."><entity id="DrugDDI.d323.s2.e0" origId="s2.p20" charOffset="66-90" type="drug" text="calcium channel blockers"/><entity id="DrugDDI.d323.s2.e1" origId="s2.p22" charOffset="103-111" type="drug" text="nitrates"/><pair id="DrugDDI.d323.s2.p0" e1="DrugDDI.d323.s2.e0" e2="DrugDDI.d323.s2.e1" interaction="false"/></sentence><sentence id="DrugDDI.d323.s3" origId="s3" text="Dose adjustments of either class of agents may be necessary."/></document>